{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T10:22:50Z","timestamp":1784024570041,"version":"3.55.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01KT1907B"],"award-info":[{"award-number":["01KT1907B"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.leukres.2023.107377","type":"journal-article","created":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T09:31:00Z","timestamp":1693128660000},"page":"107377","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["PI3K\/AKT inhibitor BEZ-235 targets CCND2 and induces G1 arrest in breast implant-associated anaplastic large cell lymphoma"],"prefix":"10.1016","volume":"133","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4431-8988","authenticated-orcid":false,"given":"Stefan","family":"Nagel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7145-2544","authenticated-orcid":false,"given":"Anja","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5263-495X","authenticated-orcid":false,"given":"Susanne","family":"Bens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivien","family":"Hauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Pommerenke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cord C.","family":"Uphoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarete","family":"Zaborski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiner","family":"Siebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilmar","family":"Quentmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2023.107377_bib1","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the world health organization classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2023.107377_bib2","doi-asserted-by":"crossref","first-page":"897","DOI":"10.3324\/haematol.2009.008250","article-title":"Anaplastic large cell lymphoma: changes in the world health organization classification and perspectives for targeted therapy","volume":"94","author":"Falini","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2023.107377_bib3","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1158\/1078-0432.CCR-12-0101","article-title":"Survival signals and targets for therapy in breast implant-associated ALK- anaplastic large cell lymphoma","volume":"18","author":"Lechner","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.leukres.2023.107377_bib4","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41379-018-0134-3","article-title":"Breast implant-associated anaplastic large cell lymphoma: a review","volume":"32","author":"Quesada","year":"2019","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.leukres.2023.107377_bib5","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ajpath.2019.09.005","article-title":"Cell of origin and immunologic events in the pathogenesis of breast implant-associated anaplastic large-cell lymphoma","volume":"190","author":"Turner","year":"2020","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.leukres.2023.107377_bib6","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.1073\/pnas.1700682114","article-title":"Cytokine receptor signaling is required for the survival of ALK-anaplastic large cell lymphoma, even in the presence of JAK1\/STAT3 mutations","volume":"114","author":"Chen","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"S1","key":"10.1016\/j.leukres.2023.107377_bib7","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1093\/asj\/sjy250","article-title":"What cytokines can tell us about the pathogenesis of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL)","volume":"39","author":"Kadin","year":"2019","journal-title":"Aesthetic Surg. J."},{"key":"10.1016\/j.leukres.2023.107377_bib8","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jpra.2021.11.006","article-title":"What are the likely causes of breast implant associated anaplastic large cell lymphoma (BIA-ALCL)?","volume":"32","author":"Lajevardi","year":"2022","journal-title":"JPRAS Open"},{"key":"10.1016\/j.leukres.2023.107377_bib9","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.3390\/cancers12113353","article-title":"BH3 mimetics for the treatment of B-cell malignancies \u2013 Insights and lessons from the clinic","volume":"12","author":"Lin","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.leukres.2023.107377_bib10","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41419-021-03500-6","article-title":"The application of BH3 mimetics in myeloid malignancies","volume":"12","author":"Parry","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.leukres.2023.107377_bib11","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.phrs.2016.03.012","article-title":"Cyclin-dependent protein kinase inhibitors including palbociclib as anticancer drugs","volume":"107","author":"Roskoski","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.leukres.2023.107377_bib12","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.3324\/haematol.2021.279410","article-title":"Rational drug combinations with CDK4\/6 inhibitors in acute lymphoblastic leukemia","volume":"107","author":"Bride","year":"2022","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2023.107377_bib13","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1038\/s41598-022-04916-6","article-title":"Inhibition of MCL1 induces apoptosis in anaplastic large cell lymphoma and in primary effusion lymphoma","volume":"12","author":"Quentmeier","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.leukres.2023.107377_bib14","first-page":"2077","article-title":"Identification of G1 kinase activity for cdk6, a novel cyclin D partner","volume":"14","author":"Meyerson","year":"1994","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.leukres.2023.107377_bib15","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1247\/csf.08019","article-title":"Migratory localization of Cyclin D2\/Cdk4 complex suggests a spatial regulation of the G1-S transition","volume":"33","author":"Wang","year":"2008","journal-title":"Cell Struct. Funct."},{"key":"10.1016\/j.leukres.2023.107377_bib16","doi-asserted-by":"crossref","first-page":"5165","DOI":"10.1038\/s41388-020-1354-9","article-title":"Senescence as a therapeutically relevant response to CDK4\/6 inhibitors","volume":"39","author":"Wagner","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2023.107377_bib17","doi-asserted-by":"crossref","first-page":"12738","DOI":"10.1074\/jbc.272.19.12738","article-title":"Differential phosphorylation of the retinoblastoma protein by G1\/S cyclin-dependent kinases","volume":"272","author":"Zarkowska","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.leukres.2023.107377_bib18","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1038\/sj.onc.1210715","article-title":"Regulation of cyclin D1 expression by mTORC signaling requires eukaryotic initiation factor 4E-binding protein 1","volume":"27","author":"Averous","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2023.107377_bib19","doi-asserted-by":"crossref","first-page":"6630","DOI":"10.1038\/sj.onc.1210490","article-title":"Glycogen synthase kinase-3\u03b2 and p38 phosphorylate cyclin D2 on Thr280 to trigger its ubiquitin\/proteasome-dependent degradation in hematopoietic cells","volume":"26","author":"Kida","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2023.107377_bib20","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/sj.leu.2404008","article-title":"Cyclin D2 dysregulation by chromosomal translocations to TCR loci in T-cell acute lymphoblastic leukemias","volume":"20","author":"Clappier","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2023.107377_bib21","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0165-4608(97)00291-4","article-title":"Genomic amplification of CCND2 is rare in non-Hodgkin lymphomas","volume":"102","author":"Andreasson","year":"1998","journal-title":"Cancer Genet. Cytogenet."},{"key":"10.1016\/j.leukres.2023.107377_bib22","first-page":"9","article-title":"The silencing of CCND2 by promoter aberrant methylation in renal cell cancer and analysis of the correlation between CCND2 methylation status and clinical features","volume":"11","author":"Wang","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.leukres.2023.107377_bib23","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41419-019-1831-7","article-title":"CDK7 inhibitor THZ1 inhibits MCL1 synthesis and drives cholangiocarcinoma apoptosis in combination with BCL2\/BCL-XL inhibitor AB T-263","volume":"10","author":"Huang","year":"2019","journal-title":"Cell. Death Dis."},{"key":"10.1016\/j.leukres.2023.107377_bib24","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S1357-2725(96)00178-1","article-title":"Regulation of CDK\/cyclin complexes during the cell cycle","volume":"29","author":"Arellano","year":"1997","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.leukres.2023.107377_bib25","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1146\/annurev.pharmtox.39.1.295","article-title":"Cyclins and cell cycle checkpoints","volume":"39","author":"Johnson","year":"1999","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.leukres.2023.107377_bib26","series-title":"Guide to Leukemia-Lymphoma Cell Lines","author":"Drexler","year":"2010"},{"key":"10.1016\/j.leukres.2023.107377_bib27","doi-asserted-by":"crossref","first-page":"8218","DOI":"10.1038\/s41598-019-44491-x","article-title":"The LL-100 panel: 100 cell lines for blood cancer studies","volume":"9","author":"Quentmeier","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.leukres.2023.107377_bib28","doi-asserted-by":"crossref","first-page":"420","DOI":"10.12688\/f1000research.111175.2","article-title":"DSMZCellDive: diving into high-throughput cell line data","volume":"11","author":"Koblitz","year":"2022","journal-title":"F1000Research"},{"key":"10.1016\/j.leukres.2023.107377_bib29","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.3390\/biomedicines10082038","article-title":"Genomic aberrations generate fusion gene FOXK2::TP63 and activate NFKB1 in cutaneous T-cell lymphoma","volume":"10","author":"Nagel","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.leukres.2023.107377_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0255622","article-title":"Identification of cell lines CL-14, CL-40 and CAL-51 as suitable models for SARS-CoV-2 infection studies","volume":"16","author":"Pommerenke","year":"2021","journal-title":"PLoS One"},{"issue":"6220","key":"10.1016\/j.leukres.2023.107377_bib31","doi-asserted-by":"crossref","first-page":"1260419","DOI":"10.1126\/science.1260419","article-title":"Tissue-based map of the human proteome","volume":"347","author":"Uhl\u00e9n","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.leukres.2023.107377_bib32","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2353\/jmoldx.2006.050083","article-title":"FISH analysis for the detection of lymphoma-associated chromosomal abnormalities in routine paraffin-embedded tissue","volume":"8","author":"Ventura","year":"2006","journal-title":"J. Mol. Diagn."},{"key":"10.1016\/j.leukres.2023.107377_bib33","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/sj.leu.2402884","article-title":"Molecular cytogenetic detection of chromosomal breakpoints in T-cell receptor gene loci","volume":"17","author":"Gesk","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2023.107377_bib34","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.1182\/blood-2005-04-1753","article-title":"Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling","volume":"106","author":"Fu","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2023.107377_bib35","doi-asserted-by":"crossref","first-page":"11339","DOI":"10.1093\/nar\/gks957","article-title":"A global DNA methylation and gene expression analysis of early human B-cell development reveals a demethylation signature and transcription factor network","volume":"40","author":"Lee","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.leukres.2023.107377_bib36","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1093\/nar\/gku1340","article-title":"Regulation of the transcriptional program by DNA methylation during human \u03b1\u03b2 T-cell development","volume":"43","author":"Rodriguez","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.leukres.2023.107377_bib37","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.celrep.2016.09.018","article-title":"Insights into the pathogenesis of anaplastic large-cell lymphoma through genome-wide DNA methylation profiling","volume":"17","author":"Hassler","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.leukres.2023.107377_bib38","doi-asserted-by":"crossref","first-page":"e104","DOI":"10.3324\/haematol.2018.196196","article-title":"DNA methylation profiling of hepatosplenic T-cell lymphoma","volume":"104","author":"Bergemann","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2023.107377_bib39","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1093\/bioinformatics\/btu049","article-title":"Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation arrays","volume":"30","author":"Aryee","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.leukres.2023.107377_bib40","unstructured":"V. Hovestadt, M. Zapatka, Enhanced copy-number variation analysis using Illumina DNA methylation arrays. DOI: 10.18129\/B9.bioc.conumee."},{"key":"10.1016\/j.leukres.2023.107377_bib41","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1756-8722-2-3","article-title":"SET-NUP214 fusion in acute myeloid leukemia- and T-cell acute lymphoblastic leukemia-derived cell lines","volume":"2","author":"Quentmeier","year":"2009","journal-title":"J. Hematol. Oncol."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212623006422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212623006422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T01:04:55Z","timestamp":1758935095000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212623006422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":41,"alternative-id":["S0145212623006422"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2023.107377","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PI3K\/AKT inhibitor BEZ-235 targets CCND2 and induces G1 arrest in breast implant-associated anaplastic large cell lymphoma","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2023.107377","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107377"}}